Metraipolis › archive › dc_3e30dc49b930

Efficacy and safety of remimazolam besylate in patients receiving mechanical ventilation: A randomized phase Ⅱa trial — Europe PMC PMID:42164587

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42164587
DOI
10.1016/j.jointm.2025.12.002
License (as archived)
solo-consultazione
Archived
2026-11-06T23:10:58.886Z
SHA-256 of the archived text
069c97d1e2c1ecb676e6e7cc4c8afb4d979d06c53df3222e1aac18245cf0fb20
Stable URL of this page
https://metraipolis.com/documento/dc_3e30dc49b930

How to cite

Efficacy and safety of remimazolam besylate in patients receiving mechanical ventilation: A randomized phase Ⅱa trial — Europe PMC PMID:42164587 — Europe PMC (en), https://europepmc.org/article/MED/42164587 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3e30dc49b930 (Metraipolis archive dc_3e30dc49b930, sha256 069c97d1e2c1ecb676e6e7cc4c8afb4d979d06c53df3222e1aac18245cf0fb20)
BibTeX
@misc{dc3e30dc49b930,
  title = {Efficacy and safety of remimazolam besylate in patients receiving mechanical ventilation: A randomized phase Ⅱa trial — Europe PMC PMID:42164587},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42164587},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3e30dc49b930; sha256 069c97d1e2c1ecb676e6e7cc4c8afb4d979d06c53df3222e1aac18245cf0fb20},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42164587. Agents can read the archived copy with the MCP tool read_document.